Abstract Treatment of irritable bowel syndrome (IBS) is challenging for both primary care
physicians and gastroenterologists because of the heterogeneity of the patient population …

Introduction Irritable bowel syndrome (IBS) is a symptom-based disorder of chronic
abdominal pain and altered bowel habits. The pathogenesis of IBS is multifactorial, leading …

New therapies are being developed for irritable bowel syndrome (IBS). These advances are
based on understanding pathophysiology or the development of medications with greater …

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders causing
patients to seek medical treatment. It is relatively resource intensive and the source of …

Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder characterized
by abdominal pain and discomfort in association with altered bowel habits. It is estimated to …

There is tremendous activity and excitement in the arena of drug development for the
treatment of the irritable bowel syndrome (IBS). Pharmacologic therapy has been largely …

Background: Irritable bowel syndrome (IBS) is currently one of the most common disorders
of the digestive system in the Western society. Almost 2 out of 10 people suffer from IBS with …

Irritable bowel syndrome (IBS) is a high prevalence disease, whose symptoms are reported
by a large number of young adults with significant effects on quality of life and social costs …

Irritable bowel syndrome (IBS) is a disorder of the brain-gut axis; the pathophysiological
mechanisms include altered colonic motility, bile acid metabolism, neurohormonal …

Importance of the field: Irritable bowel syndrome (IBS) is a common disorder with significant
health and economic consequences. The etiology of IBS is complex and appears to be …